ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Delpacibart etedesiran improves the molecular pathology of myotonic dystrophy type 1 in the phase 1/2 MARINA study.

Tanya T Kwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.